Phase II randomized trial comparing sequential first-line everolimus and second-line sunitinib versus first-line sunitinib and second-line everolimus in patients with metastatic renal cell carcinoma - Motzer, R J; Barrios, C H; Kim, T M (N Engl J Med, 2014)
et al.